Catalyst Wire Dossier Catalyst Wire Dossier

REOLYSIN

pelareorep · Oncolytics Biotech Inc
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for REOLYSIN, covering 2014-10-02 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab [Phase 1, Phase 2]

See pricing